Skip to content

Use of Dexmedetomidine as an auxiliary medication in nerve blocks to control pain in hip surgery: randomized clinical study

Use of Dexmedetomidine as an adjuvant in Peng Block for hip surgery: randomized clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-28swytb
Enrollment
Unknown
Registered
2024-09-09
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures

Interventions

This is a two-arm, double-blind, randomized controlled clinical study. A total of 63 people who meet the eligibility criteria will be probabilistically allocated to one or another intervention group u
E01.370.600.550.324

Sponsors

Instituto de Assistência Médica ao Servidor Público Estadual
Lead Sponsor
Instituto de Assistência Médica ao Servidor Público Estadual
Collaborator

Eligibility

Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients indicated for hip surgery under spinal anesthesia; of both sexes; aged between 18 and 85 years; ASA classification (American Society of Anesthesiology) I, II and III

Exclusion criteria

Exclusion criteria: Patient refusal; known sensitivity or contraindication to local anesthetics or dexmedetomidine; history of psychological disorders; localized infection at the blockage site; use of anticoagulants/coagulopathies (platelet count 1.5)

Design outcomes

Primary

MeasureTime frame
It is expected to find a reduction in post-operative pain in patients undergoing intervention, verified using the Verbal Numerical Scale (VNS) method, where zero means the absence of pain and 10 the worst pain imaginable. VNS will be assessed upon the participant's admission to the corresponding hospitalization unit, and 2, 6, 12 and 24 hours after the end of the surgery. Between 24 and 48 hours after surgery, the average score of the day will be evaluated (both at rest VNS [ENV-R]) and the VNS during coughing or movement, that is, the dynamic VNS [VNS-D]); based on the observation of a variation that is statistically significant between the pain scores of the intervention group and the control group (p<0,05)

Secondary

MeasureTime frame
It is expected to find a decrease in the consumption of dipyrone and opioids, verified through the method of reducing the request for doses of these medications; based on the finding of a statistically significant variation between the pain scores of the intervention group and the control group (p<0.05);It is expected to find a reduction in the time to start walking/physiotherapy; based on the finding of a statistically significant variation between the pain scores of the intervention group and the control group (p<0.05);It is expected to find an improvement in the quality of post-operative recovery, verified using the Quality of Recovery 40 (QoR) method; based on the finding of a statistically significant variation between the pain scores of the intervention group and the control group (p<0.05)

Countries

Brazil

Contacts

Public ContactDisnei Matos

Instituto de Assistência Médica ao Servidor Público Estadual

disneiabbade@gmail.com+55(71)99151-4891

Outcome results

None listed

Source: REBEC (via WHO ICTRP)